Delivery Order SPE2DR25D1106-SPE2DR26FJS1E
Award Date 3/16/26
Potential Completion Date 3/17/26
Potential Value $2.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,531.40 delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for Gvoke Hypopen 1-pack 1 mg/0.2 ml auto-injectors, with a completion date of March 11, 2026. The order is issued under the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical commodities globally to military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $4,187.60 under firm fixed pricing. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle running through December 2026 that provides global pharmaceutical and medical supply support to military healthcare...
- The Defense Logistics Agency issued a $4,395.02 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for Gvoke HypoGlucagon 2-pack 1 mg/0.2 ml auto-injectors. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 supporting pharmaceutical and medical supply procurement for military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $2,832.92. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $2,465.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of GVOKE Hypoepen 2-pack auto-injectors (0.5mg/0.1ml). The award represents a competitively procured, non-set-aside contract with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of GVOKE HypopenPen auto-injectors (2-pack, 1 mg/0.2 ml formulation) with a ceiling value of $1,456.72. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, and performance will be executed from the company's location in Conshohocken, Pennsylvania. The order is set for ultimate completion by August 19, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,109.11 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Gvoke HypoPen 1-Pack 1 mg/0.2 mL auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $2,066.98 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gvoke Hypoepen 2-packs (0.5mg/0.1mL auto-injectors). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. The contract is scheduled for completion by December 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $16,139.59. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,117.88 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 mL) on January 8, 2026, with a completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJS1EDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for Gvoke HypoOpen 2-pack 1 mg/0.2 ml auto-injectors, with a ceiling value of $2,404.86. Place of performance is Conshohocken, PA. The order is firm fixed price, non-competitive set-aside, and carries an ultimate completion date of March 17, 2026. The order is issued under the parent IDC held by Cencora, Inc. (AmerisourceBergen's parent organization) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 6/14/26, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/15/26 |